Inc., PerkinElmer. PKI continues to benefit from the core segment of diagnostics, rapid global growth and continued expansion of margins. Forex volatility, however, is still a problem.
PerkinElmer's shares have risen 15.8 percent, underperforming the 22.3 percent year - to-date growth of the industry.
This company, with a market capitalization of $10.11 billion, offers scientific instruments, consumables, and services t....
Tags : PerkinElmer, diagnostics, Zacks Consensus,
comments (0)